# Carglumic acid

NDC: 35573-459
Generic name: Carglumic acid
Labeler / Manufacturer: Burel Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20221219

FDA application: ANDA213395

## Active ingredients

- CARGLUMIC ACID: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"35573-459"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=35573-459
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2aee4281-402b-4cd6-9e6a-08945262e1a1